Altimmune ALT Operating margin

Operating margin at other companies

Madrigal Pharmaceuticals, Inc.MDGL

-25.1%-9.2pp

Delcath SystemsDCTH

-118.1%-56.8pp

Wave Life SciencesWVE

-75.7%-33.6pp

Mirum Pharmaceuticals, Inc.MIRM

-134.9%-151pp

Beam TherapeuticsBEAM

-226.6%-90.5pp

Agios PharmaceuticalsAGIO

-466.8%-173pp

FAQ

What is Altimmune's operating margin?

Altimmune (ALT) reported operating margin of -230,461% in Q4 2025.

How has Altimmune's operating margin changed year-over-year?

Altimmune's operating margin increased by 55.3% year-over-year, from -515,860% to -230,461%.

What is the long-term trend for Altimmune's operating margin?

Over 5 years (2020 to 2025), Altimmune's operating margin has grown at a 221.6% compound annual growth rate (CAGR), from -669.5% to -230,461%.

What does operating margin mean?

Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.